- Information for Patients
- Information for Physicians
- Rosacea Review Newsletter
- Research Grants Program
- Classification of Rosacea
- Grading of Rosacea
- Management Options For Rosacea
- Glossary
- Join Us
- How to Donate
- Press Room
- Links
- Home
Archives
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
- August 2007
- July 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- October 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- February 2006
- January 2006
Syndicate this weblogLinks
Research Grants Available
Friday, July 6, 2007
New grants are available from the National Rosacea Society (NRS) in 2007 to support research into the potential causes and other key aspects of rosacea, a chronic and often life-disruptive disorder of the facial skin and eyes, now estimated to affect 14 million Americans. The awarding of five research grants totaling $125,000 was announced earlier this year.
"Scientific understanding of this complex disorder is continuing to build as this important research grants program goes into its ninth year," said Dr. Jonathan Wilkin, chairman of the NRS medical advisory board. "We are grateful for the many thousands of contributions from rosacea patients that make this program possible."
Application forms for research grants can be obtained by contacting the National Rosacea Society, 800 South Northwest Highway, Suite 200, Barrington, Illinois 60010, telephone 888/662-5874, fax 847/382-5567, e-mail rosaceas@aol.com or by filling out the request form here. The deadline for submitting applications is September 15, 2007. Grants will be issued following selection by the medical advisory board.
Members of the medical advisory board include Dr. Jonathan Wilkin, chairman; Dr. Lynn Drake, Department of Dermatology, Harvard Medical School and former president of the American Academy of Dermatology (AAD); Dr. Mark Dahl, chairman of dermatology, Mayo Clinic Scottsdale and former AAD president; Dr. Richard Odom, professor of clinical dermatology, University of California-San Francisco and former AAD president; Dr. David Norris, chairman of dermatology, University of Colorado and former president of the Society for Investigative Dermatology; Dr. Frank Powell, Mater Misericordiae Hospital in Dublin, Ireland; Dr. Michael Detmar, associate professor of dermatology, Harvard Medical School; and Dr. Bryan Sires, clinical associate professor of ophthalmology, University of Washington.
Because the etiology of rosacea is unknown, a high priority in awarding grants will be given to studies relating to such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of rosacea. Research in such areas as epidemiology, predisposition, quality of life and relationships with environmental and lifestyle factors may also be funded.
More information on the NRS research grants program may be found at www.rosacea.org/grants/.